Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom
Author:
Affiliation:
1. Health Economics and Outcomes Research Ltd Cardiff UK
2. Global Market Access and Pricing Cambridge UK
3. Department of MedicineUniversity Hospital Llandough Cardiff UK
4. Global Market Access and Pricing Gothenburg Sweden
Funder
AstraZeneca
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13992
Reference59 articles.
1. Diagnosis and Classification of Diabetes Mellitus
2. Juvenile Diabetes Research Foundation. About Type 1 diabetes.https://jdrf.org.uk/information-support/about-type-1-diabetes/Accessed August2018.
3. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration
4. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
5. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review;JBI Evidence Synthesis;2024-07-29
2. Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review;Cost Effectiveness and Resource Allocation;2022-12-01
3. Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review;Frontiers in Pharmacology;2022-04-14
4. Sodium/glucose cotransporter 2 inhibitors for the treatment of type 1 diabetes: what are the latest developments?;Expert Opinion on Pharmacotherapy;2021-08-20
5. Dapagliflozin elevates plasma high-density lipoprotein levels and influences visceral fat gene expression in streptozotocin-induced diabetes mellitus;Journal of Pharmacy and Pharmacology;2021-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3